Utility of ATRX immunohistochemistry in diagnosis of adult diffuse gliomas
Histopathology2016Vol. 69(2), pp. 260–267
Citations Over TimeTop 10% of 2016 papers
Masako Ikemura, Junji Shibahara, Akitake Mukasa, Shunsaku Takayanagi, Koki Aihara, Nobuhito Saito, Hiroyuki Aburatani, Masashi Fukayama
Abstract
Distinct histological and molecular characteristics of adult diffuse gliomas with and without ATRX immunoreactivity indicate the utility of ATRX immunohistochemistry in diagnostic practice.
Related Papers
- → Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma(2014)270 cited
- → Stable incidence of childhood and adult glioma in the Netherlands, 1989–2003(2006)29 cited
- → P04.22 * OLIGOASTROCYTOMA DOES NOT EXIST: A MOLECULAR GENETIC REAPPRAISAL ON SINGLE-CELL LEVEL(2014)1 cited
- → GE-30 * OLIGOASTROCYTOMA DOES NOT EXIST: IN-SITU MOLECULAR GENETICS FAVORS CLASSIFICATION AS EITHER OLIGODENDROGLIOMA OR ASTROCYTOMA(2014)
- → Significance of ATRX and P53 protein expression in diffuse glioma(2018)